{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:16:14Z","timestamp":1791231374457,"version":"4.1.0"},"reference-count":119,"publisher":"Centers for Disease Control MMWR Office","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Surveill. Summ."],"DOI":"10.15585\/mmwr.ss6611a1","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T10:28:00Z","timestamp":1493893680000},"page":"1-28","source":"Crossref","is-referenced-by-count":337,"title":["Surveillance of Vaccination Coverage among Adult Populations \u2014 United States, 2015"],"prefix":"10.15585","volume":"66","author":[{"given":"Walter W.","family":"Williams","sequence":"first","affiliation":[{"name":"Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Jun","family":"Lu","sequence":"additional","affiliation":[{"name":"Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"O\u2019Halloran","sequence":"additional","affiliation":[{"name":"Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC"},{"name":"Leidos, Inc, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Kim","sequence":"additional","affiliation":[{"name":"Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Grohskopf","sequence":"additional","affiliation":[{"name":"Influenza Division, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Pilishvili","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami H.","family":"Skoff","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noele P.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Harpaz","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri E.","family":"Markowitz","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Rodriguez-Lainz","sequence":"additional","affiliation":[{"name":"Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Parker","family":"Fiebelkorn","sequence":"additional","affiliation":[{"name":"Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R1","first-page":"1057","article-title":"Estimates of deaths associated with seasonal influenza\u2014United States, 1976\u20132007.","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R2","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States.","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R3","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"63","author":"Tomczyk","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R5","doi-asserted-by":"publisher","unstructured":"Williams WW, Lu P-J, O\u2019Halloran AO, Surveillance of vaccination coverage among adult populations\u2014United States, 2014. MMWR Surveill Summ 2016;65(No. SS-1).","DOI":"10.15585\/mmwr.ss6501a1"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R6","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years and older\u2014United States, 2017.","author":"CDC","year":"2017;","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R7","unstructured":"CDC. Flu vaccination coverage, United States, 2015\u201316 influenza season. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https:\/\/www.cdc.gov\/flu\/fluvaxview\/coverage-1516estimates.htm"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm6436a1","article-title":"Influenza vaccination coverage among health care personnel\u2014United States, 2014\u201315 influenza season.","volume":"64","author":"Black","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R9","unstructured":"Ding H, Black CL, Ball S, Flu vaccination among pregnant women\u2014United States, 2015\u201316 flu season. Atlanta, GA: US Department of Health and Human Services, CDC; 2016.https:\/\/www.cdc.gov\/flu\/fluvaxview\/pregnant-coverage_1516estimates.htm"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R10","article-title":"Surveillance of influenza vaccination coverage\u2014United States, 2007\u201308 through 2011\u201312 influenza seasons.","volume":"62","author":"CDC","year":"2013","journal-title":"MMWR Surveill Summ"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R11","first-page":"997","article-title":"Estimated influenza illnesses and hospitalizations averted by influenza vaccination\u2014United States, 2012\u201313 influenza season.","volume":"62","author":"CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R12","first-page":"1151","article-title":"Estimated influenza illnesses and hospitalizations averted by vaccination\u2014United States, 2013\u201314 influenza season.","volume":"63","author":"Reed","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R13","unstructured":"13. Community Preventive Services Task Force. The guide to community preventive services. Vaccination\u2014Task Force findings. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https:\/\/www.thecommunityguide.org"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/003335491412900203","article-title":"Recommendations from the National Vaccine Advisory Committee: standards for adult immunization practice.","volume":"129","author":"National Vaccine Advisory Committee","year":"2014","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm6436a1","article-title":"Influenza vaccination coverage among health care personnel\u2014United States, 2014\u201315 influenza season.","volume":"64","author":"Black","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R16","first-page":"805","article-title":"Influenza vaccination coverage among health care personnel\u2014United States, 2013\u201314 influenza season.","volume":"63","author":"Black","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R17","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.15585\/mmwr.mm6538a2","article-title":"Influenza vaccination coverage among health care personnel\u2014United States, 2015\u201316 influenza season.","volume":"65","author":"Black","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R18","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"63","author":"Tomczyk","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R19","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.15585\/mmwr.mm6434a4","article-title":"Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"64","author":"Kobayashi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R21","first-page":"468","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older\u2014Advisory Committee on Immunization Practices (ACIP), 2012.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R22","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1586\/14760584.2014.944167","article-title":"Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.","volume":"13","author":"Sheridan","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R23","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/infdis\/jiu322","article-title":"Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.","volume":"210","author":"Koepke","year":"2014","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1001\/jamapediatrics.2015.4875","article-title":"Impact of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccinations on reported pertussis cases among those 11 to 18 years of age in an era of waning pertussis immunity\u2013a follow-up analysis.","volume":"170","author":"Skoff","year":"2016","journal-title":"JAMA Pediatr"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R25","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1080\/21645515.2015.1038442","article-title":"Prevention of pertussis through adult vaccination.","volume":"11","author":"Suryadevara","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R26","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination.","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1017\/S0031182015000979","article-title":"Pertussis immunity and epidemiology: mode and duration of vaccine-induced immunity.","volume":"143","author":"Magpantay","year":"2016","journal-title":"Parasitology"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R28","unstructured":"CDC. Long-term effectiveness of whooping cough vaccines. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. https:\/\/www.cdc.gov\/pertussis\/pregnant\/mom\/vacc-effectiveness.html"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJMc1212006","article-title":"Priming with whole-cell versus acellular pertussis vaccine.","volume":"368","author":"Liko","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R30","doi-asserted-by":"publisher","first-page":"e1716","DOI":"10.1542\/peds.2012-3836","article-title":"Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers.","volume":"131","author":"Klein","year":"2013","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R31","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women\u2014Advisory Committee on Immunization Practices (ACIP), 2012.","volume":"62","author":"CDC","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R32","unstructured":"United States Government Accountability Office. Report to Congressional Committees. Medicare\u2014many factors, including administrative challenges, affect access to Part D vaccinations. GAO-12-61. December 2011. http:\/\/www.gao.gov\/products\/GAO-12-61"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","article-title":"Barriers to the use of herpes zoster vaccine.","volume":"152","author":"Hurley","year":"2010","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3122\/jabfm.2013.01.120154","article-title":"Herpes zoster knowledge, prevalence, and vaccination rate by race.","volume":"26","author":"Joon Lee","year":"2013","journal-title":"J Am Board Fam Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R35","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R36","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","article-title":"Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized, placebo-controlled study.","volume":"211","author":"Berkowitz","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R37","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","article-title":"A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.","volume":"124","author":"Stadtmauer","year":"2014","journal-title":"Blood"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R38","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.4161\/hv.24269","article-title":"Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ\/su): a phase-I, open-label study in Japanese adults.","volume":"9","author":"Lal","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R39","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/infdis\/jit344","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults.","volume":"208","author":"Mullane","year":"2013","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R40","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.vaccine.2015.09.073","article-title":"Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults.","volume":"34","author":"Chlibek","year":"2016","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R41","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R42","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older.","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R43","article-title":"Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"63","author":"Markowitz","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R44","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R45","article-title":"\u2014","year":"2016"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R46","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/infdis\/jir341","article-title":"Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003\u20132006.","volume":"204","author":"Hariri","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/infdis\/jiv403","article-title":"Seroprevalence of 9 human papillomavirus types in the United States, 2005\u20132006.","volume":"213","author":"Liu","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R48","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/infdis\/jiu413","article-title":"Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway.","volume":"211","author":"Burger","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/infdis\/jiu414","article-title":"The cost-effectiveness of human papillomavirus vaccine catch-up programs for women.","volume":"211","author":"Chesson","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies.","volume":"13","author":"Elbasha","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R51","doi-asserted-by":"publisher","first-page":"a769","DOI":"10.1136\/bmj.a769","article-title":"Economic evaluation of human papillomavirus vaccination in the United Kingdom.","volume":"337","author":"Jit","year":"2008","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R52","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.bjc.6603575","article-title":"Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland.","volume":"96","author":"French","year":"2007","journal-title":"Br J Cancer"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1071\/SH07042","article-title":"Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia.","volume":"4","author":"Regan","year":"2007","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R54","first-page":"459","article-title":"The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan.","volume":"9","author":"Dasbach","year":"2008","journal-title":"Asian Pac J Cancer Prev"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R55","doi-asserted-by":"publisher","first-page":"164.","DOI":"10.1186\/s12885-016-2207-3","article-title":"Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China.","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Cancer"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R56","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jadohealth.2013.09.018","article-title":"Population impact of HPV vaccines: summary of early evidence.","volume":"53","author":"Hariri","year":"2013","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R57","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/sti.2009.037788","article-title":"Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.","volume":"85","author":"Fairley","year":"2009","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R58","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program.","volume":"206","author":"Tabrizi","year":"2012","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R59","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R60","doi-asserted-by":"publisher","first-page":"8443","DOI":"10.1016\/j.vaccine.2011.07.096","article-title":"The cost-effectiveness of male HPV vaccination in the United States.","volume":"29","author":"Chesson","year":"2011","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R61","unstructured":"Chesson H, Markowitz L. The cost effectiveness of quadrivalent human papillomavirus vaccination of females over age 12 years in the United States. In: Alary M, ed. Proceedings of the 19th conference of the International Society for STD Research (Quebec City, Canada); July 10\u201313, 2011; Bologna, Italy: Medimond, 2011:19\u201322."},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R62","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1007\/s11538-008-9338-x","article-title":"A multi-type HPV transmission model.","volume":"70","author":"Elbasha","year":"2008","journal-title":"Bull Math Biol"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R63","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.1016\/j.vaccine.2008.07.098","article-title":"Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model.","volume":"26","author":"Usher","year":"2008","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R64","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States.","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R65","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1471-0528.2008.01743.x","article-title":"The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6\/11\/16\/18) in the UK.","volume":"115","author":"Dasbach","year":"2008","journal-title":"BJOG"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R66","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1071\/SH07043","article-title":"A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program.","volume":"4","author":"Kulasingam","year":"2007","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R67","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.vaccine.2007.10.056","article-title":"Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: a transmission dynamic model-based evaluation.","volume":"26","author":"Insinga","year":"2007","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R68","doi-asserted-by":"publisher","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","article-title":"Human papillomavirus-associated cancers\u2014United States, 2008\u20132012.","volume":"65","author":"Viens","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R69","first-page":"258","article-title":"Human papillomavirus-associated cancers\u2014United States, 2004\u20132008.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R70","doi-asserted-by":"crossref","unstructured":"Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics 2016;137:e20151968. Doi: 10. 1542\/peds.2015-1968 Epub 2016 Feb 22.","DOI":"10.1542\/peds.2015-1968"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R71","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.2105\/AJPH.2012.301182","article-title":"Prevalence of anogenital warts among participants in private health plans in the United States, 2003\u20132010: potential impact of human papillomavirus vaccination.","volume":"103","author":"Flagg","year":"2013","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R72","doi-asserted-by":"crossref","unstructured":"Hariri S, Johnson ML, Bennett NM, Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States. Cancer 2015;121:2775-81. Doi: 10. 1002\/cncr.29266","DOI":"10.1002\/cncr.29266"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R73","doi-asserted-by":"crossref","unstructured":"Garland SM, Kjaer SK, Mu\u00f1oz N, Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis 2016;63:519\u201327. Doi: 10. 1093\/cid\/ciw354","DOI":"10.1093\/cid\/ciw354"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R74","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/OLQ.0000000000000418","article-title":". Significant reduction in the incidence of genital warts in young men 5 years into the Danish human papillomavirus vaccination program for girls and women.","volume":"43","author":"Bollerup","year":"2016","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R75","doi-asserted-by":"crossref","unstructured":"Baldur-Felskov B, Dehlendorff C, Munk C, Kjaer SK. Early impact of human papillomavirus vaccination on cervical neoplasia\u2013nationwide follow-up of young Danish women. J Natl Cancer Inst 2014;106:djt460. Doi: 10. 1093\/jnci\/djt460","DOI":"10.1093\/jnci\/djt460"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R76","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10552-014-0392-4","article-title":"Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program.","volume":"25","author":"Baldur-Felskov","year":"2014","journal-title":"Cancer Causes Control"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R77","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/cid\/cit436","article-title":"Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark.","volume":"57","author":"Blomberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R78","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/OLQ.0b013e31827bd66b","article-title":"Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.","volume":"40","author":"Baandrup","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R79","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/0009922815616245","article-title":"Human papillomavirus vaccination coverage among girls before 13 years: a birth year cohort analysis of the National Immunization Survey\u2013Teen, 2008\u20132013.","volume":"55","author":"Jeyarajah","year":"2016","journal-title":"Clin Pediatr (Phila)"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R80","doi-asserted-by":"publisher","first-page":"S412","DOI":"10.1016\/j.amepre.2015.03.005","article-title":"Racial and ethnic disparities in vaccination coverage among adult populations in the U.S.","volume":"49","author":"Lu","year":"2015","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R81","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.amepre.2005.08.012","article-title":"Influenza and pneumococcal vaccination of adults aged \u2265 65: racial\/ethnic differences.","volume":"29","author":"Singleton","year":"2005","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R82","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.amepre.2006.06.025","article-title":"The role of attitudes in understanding disparities in adult influenza vaccination.","volume":"31","author":"Lindley","year":"2006","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R83","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1056\/NEJMsa040609","article-title":"Primary care physicians who treat blacks and whites.","volume":"351","author":"Bach","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R84","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF01321480","article-title":"Differences in physician prevention practice patterns for white and minority patients.","volume":"13","author":"Gemson","year":"1988","journal-title":"J Community Health"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R85","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1525-1497.2006.00401.x","article-title":"Racial similarities in response to standardized offer of influenza vaccination.","volume":"21","author":"Schwartz","year":"2006","journal-title":"J Gen Intern Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R86","first-page":"1089","article-title":"Acceptance of pneumococcal vaccine under standing orders by race and ethnicity.","volume":"98","author":"Daniels","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R87","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/00333549111260S206","article-title":"Increasing inner-city adult influenza vaccination rates: a randomized controlled trial.","volume":"126","author":"Humiston","year":"2011","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R88","doi-asserted-by":"publisher","first-page":"S455","DOI":"10.1016\/j.amepre.2015.08.014","article-title":"Meeting the challenges of immunizing adults.","volume":"49","author":"Bridges","year":"2015","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R89","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3122\/jabfm.2013.01.120154","article-title":"Herpes zoster knowledge, prevalence, and vaccination rate by race.","volume":"26","author":"Joon Lee","year":"2013","journal-title":"J Am Board Fam Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R90","doi-asserted-by":"publisher","unstructured":"Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med 2008;121(Suppl 2):S28\u201335. 10.1016\/j.amjmed.2008.05.005","DOI":"10.1016\/j.amjmed.2008.05.005"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R91","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0749-3797(00)00263-4","article-title":"Barriers to influenza immunization in a low-income urban population.","volume":"20","author":"Armstrong","year":"2001","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R92","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1532-5415.2005.00585.x","article-title":"Factors associated with vaccination of Medicare beneficiaries in five U.S. communities: results from the racial and ethnic adult disparities in immunization initiative survey, 2003.","volume":"54","author":"Winston","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R93","unstructured":"National Foundation for Infectious Diseases. Call to action: adult vaccination saves lives. Bethesda, MD: National Foundation for Infectious Diseases; 2012. http:\/\/www.adultvaccination.org\/resources\/ cta-adult.pdf"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R94","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.amepre.2014.12.008","article-title":"Impact of health insurance status on vaccination coverage among adult populations.","volume":"48","author":"Lu","year":"2015","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R95","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.vaccine.2013.11.050","article-title":"Vaccination benefits and cost-sharing policy for non-institutionalized adult Medicaid enrollees in the United States.","volume":"32","author":"Stewart","year":"2014","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R96","doi-asserted-by":"publisher","first-page":"161","DOI":"10.7326\/M13-2332","article-title":"U.S. physicians\u2019 perspective of adult vaccine delivery.","volume":"160","author":"Hurley","year":"2014","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R97","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.2196\/resprot.5478","article-title":"Improving rates of influenza vaccination through electronic health record portal messages, interactive voice recognition calls and patient-enabled electronic health record updates: protocol for a randomized controlled trial.","volume":"5","author":"Cutrona","year":"2016","journal-title":"JMIR Res Protoc"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R98","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.2105\/AJPH.2015.302739","article-title":"A systems approach to improving Tdap immunization within 5 community-based family practice settings: working differently (and better) by transforming the structure and process of care.","volume":"105","author":"Shultz","year":"2015","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R99","unstructured":"Powelson J. Learnings from a 7-group\/6-state adult immunization collaborative, amid a shift from \u201cvolume to vale.\u201d American Medical Group Association. National Adult and Influenza Immunization Summit; May 10, 2016; Atlanta, GA. https:\/\/www.izsummitpartners.org\/summit\/2016-naiis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R100","unstructured":"Johnson C. Successful use of population analytics to increase immunization in a learning collaborative. American Medical Group Association. National Adult and Influenza Immunization Summit; May 10, 2016; Atlanta, GA. https:\/\/www.izsummitpartners.org\/summit\/2016-naiis"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R101","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3122\/jabfm.19.4.345","article-title":"Increasing rates of influenza vaccination during pregnancy: a multisite interventional study.","volume":"19","author":"Wallis","year":"2006","journal-title":"J Am Board Fam Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R102","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/AOG.0b013e31828642b1","article-title":"Improving influenza vaccination rates in pregnancy through text messaging: a randomized controlled trial.","volume":"121","author":"Moniz","year":"2013","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R103","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.vaccine.2015.11.020","article-title":"Interventions to increase the uptake of seasonal influenza vaccination among pregnant women: a systematic review.","volume":"34","author":"Wong","year":"2016","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R104","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1080\/21645515.2015.1130194","article-title":"Evidence-based vaccination strategies in obstetrics and gynecology settings: Current practices and methods for assessment.","volume":"12","author":"O\u2019Leary","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R105","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1016\/j.vaccine.2015.05.048","article-title":"Improving influenza and Tdap vaccination during pregnancy: A cluster-randomized trial of a multi-component antenatal vaccine promotion package in late influenza season.","volume":"33","author":"Chamberlain","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R106","first-page":"371","article-title":"Improving influenza vaccination rates in pregnant women.","volume":"57","author":"Sherman","year":"2012","journal-title":"J Reprod Med"},{"issue":"7","key":"key-10.15585\/mmwr.ss6611a1-201705041024-R107","doi-asserted-by":"publisher","first-page":"CD005188","DOI":"10.1002\/14651858.CD005188.pub3","article-title":"Interventions to increase influenza vaccination rates of those 60 years and older in the community.","author":"Thomas","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R108","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1016\/j.vaccine.2014.04.003","article-title":"National and state-specific estimates of place of influenza vaccination among adult populations\u2014United States, 2011\u201312 influenza season.","volume":"32","author":"Lu","year":"2014","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R109","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1370\/afm.1542","article-title":"Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience.","volume":"11","author":"Goad","year":"2013","journal-title":"Ann Fam Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R110","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/21645515.2015.1093714","article-title":"Routine immunization of adults by pharmacists: Attitudes and beliefs of the Canadian public and health care providers.","volume":"12","author":"MacDougall","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R111","first-page":"1","article-title":"Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services.","volume":"54","author":"Willis","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R112","doi-asserted-by":"publisher","unstructured":"Rolnick SJ, Parker ED, Nordin JD, Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors? Vaccine 2013;31:3928\u201335. 10.1016\/j.vaccine.2013.06.041","DOI":"10.1016\/j.vaccine.2013.06.041"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R113","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0749-3797(98)00159-7","article-title":"Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients.","volume":"16","author":"Mac Donald","year":"1999","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R114","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1017\/S0950268806006479","article-title":"Validation of influenza and pneumococcal vaccine status in adults based on self-report.","volume":"135","author":"Mangtani","year":"2007","journal-title":"Epidemiol Infect"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R115","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/S0264-410X(02)00700-4","article-title":"Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata.","volume":"21","author":"Zimmerman","year":"2003","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R116","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0749-3797(03)00120-X","article-title":"Standards for adult immunization practices.","volume":"25","author":"Poland","year":"2003","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R117","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.vaccine.2008.11.077","article-title":"Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.","volume":"27","author":"Lu","year":"2009","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R118","first-page":"758","article-title":"Influenza vaccination among pregnant women, the 2011\u201312 season.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6611a1-201705041024-R119","first-page":"753","article-title":"Influenza vaccination coverage among health-care personnel\u2014the 2011\u201312 season.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["MMWR. Surveillance Summaries"],"original-title":[],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T04:27:31Z","timestamp":1569212851000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/66\/ss\/ss6611a1.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":119,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,5,5]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.ss6611a1","relation":{},"ISSN":["1546-0738","1545-8636"],"issn-type":[{"value":"1546-0738","type":"print"},{"value":"1545-8636","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5,5]]},"published":{"date-parts":[[2017,5,5]]}}}